Parenteral Drugs (India) Ltd.
NSE: PDPL.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Govind Das Garg
- Employees
- 909
- Headquarters
- Indore, India
- IPO year
- 2010
- Market cap
- ₹101.1M
- Website
- https://www.pdindia.com
Loading PDPL…
Loading profile data…Frequently asked questions about PDPL
What does Parenteral Drugs (India) Ltd. (PDPL.NS) do?
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products...
Where does PDPL.NS trade?
Parenteral Drugs (India) Ltd. (PDPL.NS) trades on the National Stock Exchange of India.
What sector is PDPL.NS in?
Parenteral Drugs (India) Ltd. (PDPL.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Parenteral Drugs (India) Ltd.?
Govind Das Garg is the chief executive officer of Parenteral Drugs (India) Ltd. (PDPL.NS).
Where is Parenteral Drugs (India) Ltd. headquartered?
Parenteral Drugs (India) Ltd. is headquartered in India.
Does PDPL.NS pay a dividend?
Parenteral Drugs (India) Ltd. (PDPL.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PDPL.NS go public?
Parenteral Drugs (India) Ltd. (PDPL.NS) completed its initial public offering in 2010.